US Cuts $400 Million in HIV Funding to South Africa Amid Diplomatic Fallout

Washington has announced it will terminate financing for HIV and AIDS programmes in South Africa, a country that carries the world's heaviest HIV burden with more than eight million people living with the virus. The move has alarmed health advocates across sub-Saharan Africa and raises urgent questions about what happens when geopolitical disputes override public health priorities.

South Africa's fight against HIV has long depended in significant part on American dollars. Through the President's Emergency Fund for AIDS Relief — widely known as Pepfar — the United States was contributing approximately $400 million to South Africa each year up to 2025. That single funding stream covered roughly one-fifth of the country's entire HIV expenditure, making the US the largest external contributor to the programme.

The State Department has framed the withdrawal as a direct consequence of South Africa's alleged failure to adequately protect its Afrikaner minority. An official from the department confirmed that a "phased drawdown" of the funding would commence, attributing the decision to Pretoria's failure to make "demonstrable progress on policy requests." The South African government has categorically disputed those allegations, arguing that its policies are misread and misrepresented by Washington.

Relations between the two countries had been deteriorating since President Donald Trump's return to the White House. After his inauguration, Trump signed an executive order accusing South Africa of dismantling equal opportunities and stoking violence against what he described as "racially disfavored landowners." South Africa's government fired back, insisting those claims fundamentally mischaracterise its Black Economic Empowerment policy — legislation specifically crafted to dismantle the economic legacy of apartheid and redistribute opportunity more equitably.

Pretoria's health ministry moved swiftly to reassure its citizens, clarifying that the supply of antiretroviral drugs operates under a separate government-funded budget and would not face an immediate shortfall as a result of the American withdrawal. Officials further disclosed that South Africa had already drafted a self-reliance plan aimed at reducing the country's dependence on external donors in its HIV response.

For Kenya and other African nations that continue to rely on donor funding for essential health services, the episode offers a sobering warning. When diplomatic disputes can trigger the sudden withdrawal of billions of shillings worth of health support, the case for building robust domestic health financing becomes impossible to ignore. Governments across the continent face mounting pressure to treat donor funding as a bridge — not a permanent solution — to long-term health security.